Immunosuppressive Therapies
Fewer than 50% of patients with sarcoidosis treated within year of diagnosis
Less than half of patients with sarcoidosis had been treated by the 1-year mark since being diagnosed with the condition, according to results published in CHEST.
Guidelines
With heart transplant advances, a quest for ‘holy grail’ of tolerance, improved outcomes
Heart transplantation is considered standard therapy for patients with end-stage HF, and survival and the availability of donor hearts have continued to improve over time.
Questions remain on patient costs, formulary for expanded immunosuppressive drug benefit
Demand for transplantation has rapidly increased around the world during the past decade due to an increase in incidence of comorbidities leading to organ failure along with a rise in longevity in patient years.
Nearly one-third of rheumatology drug regimens shifted at time of COVID-19 vaccination
As many as 27.9% of immunomodulatory or immunosuppressive regimens were changed around the time of COVID-19 vaccination, with patients responsible for most modifications, according to data published in The Lancet Rheumatology.
Young man presents with new distortion
A 19-year-old man presented to the New England Eye Center’s retina service with new distortion and a scotoma in the left eye.